Abiopharma

🔍 HENSON HEIDI (Director)

Company: PepGen Inc. (PEPG)

Report Date: 2026-06-18

Detailed Transactions and Holdings:

• Acquired 34,000 shares of Stock Option (Right to Buy) at $1.79 per share (Derivative)
  Date: 2026-06-18 | Code: A | Expires: 2036-06-17 | equity_swap_involved: 0 | shares_owned_after: 34,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This option shall vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting; provided, however, that all vesting shall cease if the individual ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting.